Brand against brand · teriparatide and abaloparatide
Forteo vs Tymlos
From the two FDA labels, read Published by PepVault
Forteo is teriparatide, a parathyroid hormone analog (PTH 1-34), from Eli Lilly; Tymlos is abaloparatide, a parathyroid hormone-related peptide analog (PTHrP 1-34), from Radius Health.
FDA approved Forteo for osteoporosis at high risk of fracture in women after menopause, in men, and in people on long-term steroid pills. Tymlos is approved for osteoporosis at high risk of fracture in women after menopause, and to raise bone density in men.
Label against label
| Compared | Forteo | Tymlos |
|---|---|---|
| Active ingredient | teriparatide | abaloparatide |
| Class | parathyroid hormone analog (PTH 1-34) | parathyroid hormone-related peptide analog (PTHrP 1-34) |
| Maker | Eli Lilly | Radius Health |
| Approved for | Osteoporosis at high risk of fracture (women after menopause, men, steroid use) | Osteoporosis at high risk of fracture (women after menopause, men) |
| Forms | Prefilled pen | Prefilled pen |
| How often | once a day | once a day |
| Starting dose | 20 mcg a day | 80 mcg a day |
| Top dose on the label | 20 mcg a day | 80 mcg a day |
| Most reported side effect | Pain, 21.3% on 20 mcg (placebo 20.5%) | Calcium in the urine (hypercalciuria), 11% on 80 mcg (placebo 9%) |
| Boxed warning | None | None |
| First approved | 2002 | 2017 |
Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.
The two dosing schedules
This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.
Forteo, once a day
One dose on the label: 20 mcg once a day.
Tymlos, once a day
One dose on the label: 80 mcg once a day.

A missed dose, on each label
The trial evidence
Questions
What is the difference between Forteo and Tymlos?
Forteo is teriparatide, a parathyroid hormone analog (PTH 1-34); Tymlos is abaloparatide, a parathyroid hormone-related peptide analog (PTHrP 1-34). Their labels approve them for different uses and set different schedules.
What are Forteo and Tymlos approved for?
Forteo is approved for osteoporosis at high risk of fracture in women after menopause, in men, and in people on long-term steroid pills. Tymlos is approved for osteoporosis at high risk of fracture in women after menopause, and to raise bone density in men.
How often are Forteo and Tymlos taken?
Forteo is taken once a day, as an injection; Tymlos once a day, as an injection.
What are the dose ranges of Forteo and Tymlos?
On their labels, Forteo runs 20 mcg once a day, and Tymlos 80 mcg once a day. A prescriber sets the actual dose.
What is the most common side effect of Forteo and Tymlos?
On Forteo’s label: pain, 21.3% on 20 mcg (placebo 20.5%). On Tymlos’s: calcium in the urine (hypercalciuria), 11% on 80 mcg (placebo 9%).
Sources
- FORTEO (teriparatide injection), for subcutaneous use, FDA label on DailyMed (version 44, published Aug 19, 2026; read Nov 18, 2026)
- TYMLOS (abaloparatide) injection, for subcutaneous use, FDA label on DailyMed (version 19, published Aug 17, 2026; read Nov 18, 2026)
- Drugs@FDA, NDA 021318 (Forteo, the pen; application first approved 2002)
- Drugs@FDA, NDA 208743 (Tymlos, the pen; application first approved 2017)
PepVault is not affiliated with Eli Lilly. Forteo is a trademark of its owner. PepVault is not affiliated with Radius Health. Tymlos is a trademark of its owner.